The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Anti Asthma Drugs-Global Market Insights and Sales Trends 2024
Synopsis
Asthma is a chronic lung disease characterized by hyper responsiveness of tracheobronchial smooth muscle to stimuli, resulting in narrowing and inflammation of air tubes, accompanied by increased secretion, swelling and build-up of tissue fluid. Symptoms include tight chest, wheezing, cough and may be limitation of activity due to difficulty in breathing.
The global Anti Asthma Drugs market size is expected to reach US$ 27190 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Anti Asthma Drugs in various end use industries. The expanding demands from the Clinics, Hospitals and Other, are propelling Anti Asthma Drugs market. Bronchodilators, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Leukotriene Antagonists segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Anti Asthma Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Anti Asthma Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Anti Asthma Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Anti Asthma Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Anti Asthma Drugs covered in this report include GlaxoSmithKline, Merck & Co, AstraZeneca, F. Hoffmann-La Roche, Teva Pharmaceutical, Novartis International, Boehringer Ingelheim and Sunovion Pharmaceuticals, etc.
The global Anti Asthma Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GlaxoSmithKline
Merck & Co
AstraZeneca
F. Hoffmann-La Roche
Teva Pharmaceutical
Novartis International
Boehringer Ingelheim
Sunovion Pharmaceuticals
Global Anti Asthma Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Anti Asthma Drugs market, Segment by Type:
Bronchodilators
Leukotriene Antagonists
Mast Cell Stabilizers
Corticosteroids
Monoclonal Antibody
Global Anti Asthma Drugs market, by Application
Clinics
Hospitals
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Anti Asthma Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Anti Asthma Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Asthma is a chronic lung disease characterized by hyper responsiveness of tracheobronchial smooth muscle to stimuli, resulting in narrowing and inflammation of air tubes, accompanied by increased secretion, swelling and build-up of tissue fluid. Symptoms include tight chest, wheezing, cough and may be limitation of activity due to difficulty in breathing.
The global Anti Asthma Drugs market size is expected to reach US$ 27190 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Anti Asthma Drugs in various end use industries. The expanding demands from the Clinics, Hospitals and Other, are propelling Anti Asthma Drugs market. Bronchodilators, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Leukotriene Antagonists segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Anti Asthma Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Anti Asthma Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Anti Asthma Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Anti Asthma Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Anti Asthma Drugs covered in this report include GlaxoSmithKline, Merck & Co, AstraZeneca, F. Hoffmann-La Roche, Teva Pharmaceutical, Novartis International, Boehringer Ingelheim and Sunovion Pharmaceuticals, etc.
The global Anti Asthma Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GlaxoSmithKline
Merck & Co
AstraZeneca
F. Hoffmann-La Roche
Teva Pharmaceutical
Novartis International
Boehringer Ingelheim
Sunovion Pharmaceuticals
Global Anti Asthma Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Anti Asthma Drugs market, Segment by Type:
Bronchodilators
Leukotriene Antagonists
Mast Cell Stabilizers
Corticosteroids
Monoclonal Antibody
Global Anti Asthma Drugs market, by Application
Clinics
Hospitals
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Anti Asthma Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Anti Asthma Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Anti Asthma Drugs Market Overview
1.1 Anti Asthma Drugs Product Overview
1.2 Anti Asthma Drugs Market Segment by Type
1.2.1 Bronchodilators
1.2.2 Leukotriene Antagonists
1.2.3 Mast Cell Stabilizers
1.2.4 Corticosteroids
1.2.5 Monoclonal Antibody
1.3 Global Anti Asthma Drugs Market Size by Type
1.3.1 Global Anti Asthma Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Anti Asthma Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Anti Asthma Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Anti Asthma Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Anti Asthma Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Anti Asthma Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Anti Asthma Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Anti Asthma Drugs Sales Breakdown by Type (2018-2023)
2 Global Anti Asthma Drugs Market Competition by Company
2.1 Global Top Players by Anti Asthma Drugs Sales (2018-2023)
2.2 Global Top Players by Anti Asthma Drugs Revenue (2018-2023)
2.3 Global Top Players by Anti Asthma Drugs Price (2018-2023)
2.4 Global Top Manufacturers Anti Asthma Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Anti Asthma Drugs Market Competitive Situation and Trends
2.5.1 Anti Asthma Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Anti Asthma Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti Asthma Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Anti Asthma Drugs Market
2.8 Key Manufacturers Anti Asthma Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Anti Asthma Drugs Status and Outlook by Region
3.1 Global Anti Asthma Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Anti Asthma Drugs Historic Market Size by Region
3.2.1 Global Anti Asthma Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Anti Asthma Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Anti Asthma Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Anti Asthma Drugs Forecasted Market Size by Region
3.3.1 Global Anti Asthma Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Anti Asthma Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Anti Asthma Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Anti Asthma Drugs by Application
4.1 Anti Asthma Drugs Market Segment by Application
4.1.1 Clinics
4.1.2 Hospitals
4.1.3 Other
4.2 Global Anti Asthma Drugs Market Size by Application
4.2.1 Global Anti Asthma Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Anti Asthma Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Anti Asthma Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Anti Asthma Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Anti Asthma Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Anti Asthma Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Anti Asthma Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Anti Asthma Drugs Sales Breakdown by Application (2018-2023)
5 North America Anti Asthma Drugs by Country
5.1 North America Anti Asthma Drugs Historic Market Size by Country
5.1.1 North America Anti Asthma Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Anti Asthma Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Anti Asthma Drugs Sales in Value by Country (2018-2023)
5.2 North America Anti Asthma Drugs Forecasted Market Size by Country
5.2.1 North America Anti Asthma Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Anti Asthma Drugs Sales in Value by Country (2024-2029)
6 Europe Anti Asthma Drugs by Country
6.1 Europe Anti Asthma Drugs Historic Market Size by Country
6.1.1 Europe Anti Asthma Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Anti Asthma Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Anti Asthma Drugs Sales in Value by Country (2018-2023)
6.2 Europe Anti Asthma Drugs Forecasted Market Size by Country
6.2.1 Europe Anti Asthma Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Anti Asthma Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Anti Asthma Drugs by Region
7.1 Asia-Pacific Anti Asthma Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Anti Asthma Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Anti Asthma Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Anti Asthma Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Anti Asthma Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Anti Asthma Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Anti Asthma Drugs Sales in Value by Region (2024-2029)
8 Latin America Anti Asthma Drugs by Country
8.1 Latin America Anti Asthma Drugs Historic Market Size by Country
8.1.1 Latin America Anti Asthma Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Anti Asthma Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Anti Asthma Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Anti Asthma Drugs Forecasted Market Size by Country
8.2.1 Latin America Anti Asthma Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Anti Asthma Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Anti Asthma Drugs by Country
9.1 Middle East and Africa Anti Asthma Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Anti Asthma Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Anti Asthma Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Anti Asthma Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Anti Asthma Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Anti Asthma Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Anti Asthma Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 GlaxoSmithKline
10.1.1 GlaxoSmithKline Company Information
10.1.2 GlaxoSmithKline Introduction and Business Overview
10.1.3 GlaxoSmithKline Anti Asthma Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 GlaxoSmithKline Anti Asthma Drugs Products Offered
10.1.5 GlaxoSmithKline Recent Development
10.2 Merck & Co
10.2.1 Merck & Co Company Information
10.2.2 Merck & Co Introduction and Business Overview
10.2.3 Merck & Co Anti Asthma Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Merck & Co Anti Asthma Drugs Products Offered
10.2.5 Merck & Co Recent Development
10.3 AstraZeneca
10.3.1 AstraZeneca Company Information
10.3.2 AstraZeneca Introduction and Business Overview
10.3.3 AstraZeneca Anti Asthma Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 AstraZeneca Anti Asthma Drugs Products Offered
10.3.5 AstraZeneca Recent Development
10.4 F. Hoffmann-La Roche
10.4.1 F. Hoffmann-La Roche Company Information
10.4.2 F. Hoffmann-La Roche Introduction and Business Overview
10.4.3 F. Hoffmann-La Roche Anti Asthma Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 F. Hoffmann-La Roche Anti Asthma Drugs Products Offered
10.4.5 F. Hoffmann-La Roche Recent Development
10.5 Teva Pharmaceutical
10.5.1 Teva Pharmaceutical Company Information
10.5.2 Teva Pharmaceutical Introduction and Business Overview
10.5.3 Teva Pharmaceutical Anti Asthma Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Teva Pharmaceutical Anti Asthma Drugs Products Offered
10.5.5 Teva Pharmaceutical Recent Development
10.6 Novartis International
10.6.1 Novartis International Company Information
10.6.2 Novartis International Introduction and Business Overview
10.6.3 Novartis International Anti Asthma Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Novartis International Anti Asthma Drugs Products Offered
10.6.5 Novartis International Recent Development
10.7 Boehringer Ingelheim
10.7.1 Boehringer Ingelheim Company Information
10.7.2 Boehringer Ingelheim Introduction and Business Overview
10.7.3 Boehringer Ingelheim Anti Asthma Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Boehringer Ingelheim Anti Asthma Drugs Products Offered
10.7.5 Boehringer Ingelheim Recent Development
10.8 Sunovion Pharmaceuticals
10.8.1 Sunovion Pharmaceuticals Company Information
10.8.2 Sunovion Pharmaceuticals Introduction and Business Overview
10.8.3 Sunovion Pharmaceuticals Anti Asthma Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Sunovion Pharmaceuticals Anti Asthma Drugs Products Offered
10.8.5 Sunovion Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Anti Asthma Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Anti Asthma Drugs Industrial Chain Analysis
11.4 Anti Asthma Drugs Market Dynamics
11.4.1 Anti Asthma Drugs Industry Trends
11.4.2 Anti Asthma Drugs Market Drivers
11.4.3 Anti Asthma Drugs Market Challenges
11.4.4 Anti Asthma Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Anti Asthma Drugs Distributors
12.3 Anti Asthma Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
